This is a preview of subscription content, log in via an institution to check access.
References
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Quetiapine fumarate. Internet Document : [2 pages], 19 Mar 2019. Available from: URL: http://www.pmda.go.jp/files/000228666.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Preparations containing vonoprazan fumarate. Internet Document : [4 pages], 19 Mar 2019. Available from: URL: http://www.pmda.go.jp/files/000228668.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Clozapine. Internet Document : [1 page], 19 Mar 2019. Available from: URL: http://www.pmda.go.jp/files/000228667.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Denosumab (genetical recombination) (120 mg product). Internet Document : [2 pages], 19 Mar 2019. Available from: URL: http://www.pmda.go.jp/files/000228669.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Intravenous injection products containing sorbitol or fructose as excipient. Internet Document : [2 pages], 19 Mar 2019. Available from: URL: http://www.pmda.go.jp/files/000228670.pdf
Rights and permissions
About this article
Cite this article
Japan's PMDA investigation results for March 2019. Reactions Weekly 1747, 2 (2019). https://doi.org/10.1007/s40278-019-59643-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-59643-3